Home | The Oncologist Community

Community Feature

This series examines how racism affects the prevention, treatment, and delivery of care to minority communities, and to what extent we have adequately incorporated a culture of equity in all phases of our work and our personal lives. To this end, The Oncologist has invited the submission of papers on a broad spectrum of topics, from disparities in outcomes, to the recruitment and training of minority cancer physicians and scientists, to the personal experiences of minority professionals as they practice cancer medicine and pursue careers in the academic community.

Read the Collection.

Discussions with Don S. Dizon

Follow @drdonsdizon

Don S. Dizon is Professor of Medicine at Brown University, the Director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, Director of Medical Oncology and the Oncology Sexual Health First Responders Clinic at Rhode Island Hospital.

On Cancer, Conversations, and Culture

May 7, 2021

Families are integral in the course of a patient's cancer treatment. In this month's blog, Don Dizon and Shaalan Beg discuss what happens when the family asks that the cancer diagnosis not be disclosed to the patient.

Immune-Related Adverse Events

Immunotherapy enhances a cancer patient’s immune system to fight an array of cancers. Immune checkpoint blockade can, however, induce inflammatory side effects known as immune-related Adverse Events (irAE). Because these rare but serious complications need to be quickly detected and properly treated, The Oncologist is devoting a new series designed to enhance the care of patients who may well benefit from therapeutic strategies that involve one or more these powerful immunotherapies.

Read about our irAE collection

PMC: Molecular Tumor Board

Precision Medicine Clinic: Molecular Tumor Board is a case-based series designed to help clinicians optimize molecular testing for their patients. The Editors of The Oncologist encourage institutions to share their findings and experiences to help improve the precision of genomic oncology and fulfill its promise of improved outcomes for patients. This collection highlights a diverse set of patients exhibiting a range of tumor types and mutations.

Read our PMC collection

Cancer Care & the Opioid Crisis

Opioids form the cornerstone of pain management in cancer patients, but the crisis of opioid addiction has resulted in significant challenges facing patients, physicians, lawmakers, and communities across the nation. This series is focused to help clinicians manage the opioid crisis while ensuring adequate pain management for their patients.

Read about our Opioid collection

Recent Newsletters

04/15/21

04/15/21

04/15/21

03/18/21

03/18/21

03/18/21

02/18/21

Read the Collection.

Discussions with Don S. Dizon